Cargando…
Accumulation of (111)In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Coadministration of Targeting Ligand
The successful use of targeted radionuclide therapy in the treatment of solid tumours may be limited by radioresistance, which necessitates delivery of a high dose of radioactivity. Nanoparticle (NP)-based delivery systems possess a large surface area for attachment of radioisotopes and so offer a s...
Autores principales: | Song, Lei, Able, Sarah, Johnson, Errin, Vallis, Katherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646733/ https://www.ncbi.nlm.nih.gov/pubmed/29071190 http://dx.doi.org/10.7150/ntno.19952 |
Ejemplares similares
-
(111)In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
por: Gill, Martin R., et al.
Publicado: (2018) -
EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer
por: Song, Lei, et al.
Publicado: (2016) -
Indium-111 labeled leukocyte accumulation in extremity soft tissue sarcoma
por: Fong, Victor, et al.
Publicado: (2017) -
Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using (111)In-bevacizumab
por: Patel, Neel, et al.
Publicado: (2017) -
An (111)In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells
por: Gill, Martin R., et al.
Publicado: (2020)